Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites
about
Schistosomiasis as a disease of stem cellsStructural and Functional Characterization of the Enantiomers of the Antischistosomal Drug OxamniquineDrug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7The NIH-NIAID Schistosomiasis Resource Center at the Biomedical Research Institute: Molecular ReduxApplication of RNAi to Genomic Drug Target Validation in SchistosomesThe Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg DevelopmentStructure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoniExploring molecular variation in Schistosoma japonicum in ChinaIvermectin - Old Drug, New Tricks?The contribution of mass drug administration to global health: past, present and future.Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.Exposure to hycanthone alters chromatin structure around specific gene functions and specific repeats in Schistosoma mansoniEfficient linkage mapping using exome capture and extreme QTL in schistosome parasites.Ion channels and drug transporters as targets for anthelmintics.Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.New insights into the genetic diversity of Schistosoma mansoni and S. haematobiumin YemenCan human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt?Whole genome resequencing of the human parasite Schistosoma mansoni reveals population history and effects of selectionSchistosome infectivity in the snail, Biomphalaria glabrata, is partially dependent on the expression of Grctm6, a Guadeloupe Resistance Complex proteinReal-time PCR for sexing Schistosoma mansoni cercariae.WormBase ParaSite - a comprehensive resource for helminth genomics.Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy.Hybridizations within the Genus Schistosoma: implications for evolution, epidemiology and control.Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.Something old, something new: is praziquantel enough for schistosomiasis control?(Epi)genetic Inheritance in Schistosoma mansoni: A Systems Approach.Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy.Inhibition of Tapeworm Thioredoxin and Glutathione Pathways by an Oxadiazole N-Oxide Leads to Reduced Mesocestoides vogae Infection Burden in Mice.Clearance of schistosome parasites by resistant genotypes at a single genomic region in Biomphalaria glabrata snails involves cellular components of the hemolymph.Polypyridylruthenium(II) complexes exert in vitro and in vivo nematocidal activity and show significant inhibition of parasite acetylcholinesterases.A genome resequencing-based genetic map reveals the recombination landscape of an outbred parasitic nematode in the presence of polyploidy and polyandry.Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.Antischistosomal agents: state of art and perspectives.How has the genomics era impacted schistosomiasis drug discovery?Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.Schistosomiasis therapeutics: whats in the pipeline?Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.Strongyloides stercoralis and relatives: recent advances in general and molecular biology.Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
P2860
Q26743434-078C9E7F-0786-42D4-A5CE-A60F17CA0ED8Q27303947-157DD71C-77AB-4D51-A628-5D2DD9F6122BQ27304597-775EDDC2-1E21-4714-9E91-51B72266ABFDQ28079535-4B493FC7-2EB8-48FA-A66D-DFFB63360238Q28547348-C6D7087D-E70E-4F9C-A555-2CB0EC857268Q28551820-527DCFD8-7E03-42CC-BC3F-10BF13746E63Q28552326-A0661E9D-7111-4007-817C-AB950A5182B3Q28606875-A16BBEB7-7B47-401E-9AA3-C55F2D661018Q30250918-27A28CED-C606-48C2-AE31-2E1081C0795DQ30388508-02418E33-3F51-4DB3-9C80-C6B94016BA64Q30772877-DACBF693-B489-40D2-A81A-121091AF5E94Q33906952-0BD8BCF4-B69D-4F95-857C-50327756558AQ33984648-176EED2E-0DB5-4EC6-A2FA-79A84445E8E8Q34782668-3FF21562-B3BB-434C-BE71-82C90AB2ECB0Q35223902-3EB8DD16-8014-4DA6-BEB1-4F96793CD939Q35813630-47401C23-AE1E-46B0-98CE-2F5E64F50BCAQ35852720-A0E725C6-1CF4-4D27-BD78-72203109BEB5Q35924330-0665C3FE-20C9-4EDB-B67A-78EB56E8827DQ36269564-E870A7A0-9515-49C7-9471-22C5AA21F655Q36827411-10F1AEE6-FBC7-4417-BDD5-76BB51BA92A8Q38375438-2DB6EC9C-675E-401F-92F7-1C5C84005078Q38867663-4CFBE720-DD04-4EA2-B67F-DFAEFE87DEF8Q38940104-7DBC0A32-482F-46C0-8DA7-2C9CB1A99784Q38977668-C9FEB288-DD56-4A67-B039-5DB1A6A2BD21Q39004194-93724F84-18EA-4152-95A9-8A5D257E7F66Q39063692-3308F079-C0CB-4737-83E7-F6A89A2A1913Q39188232-08F6696C-547D-4455-8DFE-26148A1F8886Q40201632-6E7F8675-0D0F-4171-9BCC-9B1B26084A24Q40777879-090EE840-BF0E-4EB9-84F5-366069232C96Q43366407-48A6F30A-2CAD-4E3D-B22A-BAFC736B9AD4Q47146811-A8C80CF5-7654-4B95-99C6-BB8558CE94CFQ47266449-E025AB11-CD84-4DFB-88B8-91B21FDC0B71Q47310292-895A32F6-CBA1-4455-92BD-02F0F1CA0CD8Q47784982-66B2AD61-40EB-4C9D-B82C-394DC63439AFQ48478663-299C904F-D919-4F6E-8E07-9453E1D5E413Q49197054-0843287D-7255-4840-AE91-057F23F07749Q50966400-2300BB7D-1ED9-4D5E-9C45-D1A76000B276Q52699502-79E13D95-80D0-42B5-AE28-33678B32AA47Q55006255-EAC8EFC9-9815-4948-84A3-302493D6D04FQ55438554-151F1E52-6303-4DFA-8BF9-AC344ED2EA0F
P2860
Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@ast
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@en
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@nl
type
label
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@ast
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@en
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@nl
prefLabel
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@ast
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@en
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@nl
P2093
P2860
P3181
P356
P1433
P1476
Genetic and Molecular Basis of ...... ction in Schistosome Parasites
@en
P2093
Alessandra Guidi
Alexander B Taylor
Annalisa Basso
Claudia Carvalho-Queiroz
Claudia L L Valentim
Donato Cioli
Doug E Frantz
Frédéric D Chevalier
Hector Aguilar
Livia Pica-Mattoccia
P2860
P304
P3181
P356
10.1126/SCIENCE.1243106
P407
P577
2013-12-13T00:00:00Z